4Dougherty TJ. Photosensitizers: therapy and detection of malignant tumors Photochem. Photobiol, 1987,45: 879～889.
5Krogh GV. Clinical relevance and evaluation of genitoanal papillomavirus infection in the male. Semin Dermatol, 1992,11: 229～240.
6Loh CS, Macrobert A J, Bedwell J, et al. Oral versus intravenous administration of 5-aminolevulinic acid for photodynamic therapy. Br J Cancer, 1993,68:41～51.
7Ross EV, Romero, R, Kollias N, et al. Selectivity of prototorphyrin IXfluorescence for condylomata after topical application of 5-aminolivulinicacid: implications for photodynamic treatment.Br J Dermatol, 1997,137:736～742.
8Lofgren LA, Ronn AM, Nouri M, et al. Efficacy of intravenous deltaaminolaevulinic acid photodynamic therapy on rabbit papillomas. Br JCancer, 1995,72: 857～864.
9Wang XL,Wang HW,Wang HS,et al.Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata.Br J Dermatol,2004,151:880-885.
10Kim YT,Thomas NF,Kessis TD,et al.p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias:evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.Hum Pathol,1996,27:389-395.
